Shareholders approve acquisition of Aptose by Hanmi Pharmaceutical in "Go Private" transaction TUS+VEN+AZA triplet frontline therapy continues to demonstrate favorable safety and high rates of efficac ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results